However, changes in NfL levels are not limited to HD but are also observed in other neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis, thus making NfL less specific for the diagnosis of HD. This evidence concerns the gene NEFL and early-onset autosomal dominant Alzheimer disease.